“Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023021, Feb. 2023, doi: 10.4084/MJHID.2023.021.